Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
It has also been reported that exenatide and liraglutide induced an increased concentration of ANP through the GLP-1 receptor-dependent pathway (108)
While comprehensive national data is limited, GLP-1 receptor agonists represent a major therapeutic class for type 2 diabetes, with the majority of current users having diabetes as their primary indication
Know What to Expect From GLP-1 Fatigue Although fatigue isnt officially listed as a side effect of GLP-1 medications, many people experience tiredness, especially during the first few weeks of treatment
Presented for research literature review only Roland PD (2001)
Gallbladder events are relatively uncommon but occur slightly more often than with placebo